Concepedia

Yongfu Xu

YX

Statistics

Publications

7

Citations

138

H-Index

7

Active since

2014

Affiliations

Wenzhou Medical University(Current)

Zhejiang Taizhou Hospital

Eastern Hepatobiliary Surgery Hospital

Second Military Medical University

Yongfu Xu is an author at Wenzhou Medical University specializing in hepatocellular carcinoma, liver cancer, and medicine.

ORCID

Publications per year

2014–2024

7

Publications

7

Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial–mesenchymal transition

Yongfu Xu, Binfeng Wang, Fabiao Zhang et al. · OncoTargets and Therapy · 2017 · 47 citations · Full text

, , +17

Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma

Yongfu Xu, Hai-Xiong Han, Fabiao Zhang et al. · Oncology Letters · 2014 · 30 citations · Full text

, , +17

SNHG3 regulates NEIL3 via transcription factor E2F1 to mediate malignant proliferation of hepatocellular carcinoma

Fabiao Zhang, Jie Lu, Jian Yang et al. · Immunogenetics · 2022 · 15 citations

, , +11

Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma

Fabiao Zhang, Binfeng Wang, Wenlong Zhang et al. · Current Cancer Drug Targets · 2024 · 14 citations

, , +17

Rpb3 promotes hepatocellular carcinoma through its N-terminus

Zheping Fang, Bei‐Ge Jiang, Fabiao Zhang et al. · Oncotarget · 2014 · 12 citations · Full text

, , +11

1–5 of 7